- Articles
- /Healthcare Research
- /Medication Access Report 2025
At-a-glance
2025 Medication Access Report
As healthcare innovation accelerates, fragmentation has the potential to intensify — widening existing gaps and forming new barriers. Discover how the landscape is shifting and what is needed to bridge the gaps between patients, prescribers, payers and pharmacies. Get an overview of key insights below, then request a full report for deeper analysis and data.
Current challenges facing medication access
Rising costs, complex therapies and regulatory reforms heighten the urgency for patients seeking access to medications. Integrated solutions designed to close adherence gaps and improve patient outcomes are more essential — and more achievable — than ever before.
- 65%
of patients surveyed experienced some kind of delay in accessing their medication.[0]
- 73%
of providers agree that claim denials are increasing.[0]
- 94%
of physicians say that the prior authorization process delays necessary patient care.[0]
- 84%
of pharmaceutical decision makers plan to increase their spending on access in the next five years.[0]
Transforming Healthcare, together
Every day, patients face barriers to accessing the medications they need to live healthier lives. The 2025 Medication Access Report: Barriers to Bridges challenges us to think differently, work together and build a healthcare future that is more connected, compassionate and accessible for all.
Download our most recent report on the barriers to medication access and explore this year's key insights.
— Kevin Kettler, President, CoverMyMeds
Embracing a more dynamic patient journey
Rethinking the outdated, linear patient journey helps unlock more comprehensive access strategies — turning today's challenges into opportunities for better patient outcomes.
Patients face unique and evolving challenges across access, affordability and adherence. These factors are deeply interconnected, requiring multidimensional solutions tailored to individual needs.
Growing demand for specialty medications
Specialty pharmacies have become critical to the prior auth and insurance processes, demanding more data-driven, automated solutions to provide personalized support, streamline care coordination and improve outcomes for patients with complex health conditions.
- $68b+
is the estimated value of the specialty drug market.[0]
In 2023, the specialty pharmaceutical market was valued at around $68.3 billion and is expected to reach approximately $1,532.8 billion by 2033.
- 75%
of drug launches are expected to be specialty[0]
- 56%
of total drug spend is on specialty drugs[0]
“Medication is the most powerful tool we have to keep our patients out of the hospital.”
patient support programs
Funded but underutilized
Patient support programs help people access, afford, and adhere to their prescribed medications. Yet too many patients don’t know these programs exist, or they struggle to navigate the process.
Stay ahead of the curve
Step beyond traditional solutions and explore the potential of dimensionalized access strategies. Join industry leaders shaping the future of healthcare — fill out the form to get the full 2025 Medication Access Report delivered straight to your inbox.